Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 0.840-0.840 for the period. The company issued revenue guidance of $12.0 billion-$12.0 billion.
Daiichi Sankyo Stock Performance
Shares of DSNKY opened at $28.66 on Friday. Daiichi Sankyo has a 12 month low of $25.11 and a 12 month high of $42.48. The company has a 50-day moving average price of $28.50 and a two-hundred day moving average price of $33.03.
Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.22 EPS for the quarter.
About Daiichi Sankyo
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Featured Stories
- Five stocks we like better than Daiichi Sankyo
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Turnaround Stocks in the Early Innings With More Upside to Come
- How to Profit From Value Investing
- Whirlpool: Buy This High-Yielding Value Before It Spins Higher
- How to Invest in Insurance Companies: A Guide
- Commvault Systems: Share Price Primed to Vault Higher in 2025
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
